Patricia L Judson

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi request reprint Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer
    Patricia L Judson
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, 420 Delaware Street Southeast, MMC 395, Minneapolis, MN 55455, USA
    Gynecol Oncol 91:389-94. 2003
  2. ncbi request reprint A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer
    Patricia L Judson
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis, MN 55455, USA
    Gynecol Oncol 93:667-70. 2004
  3. ncbi request reprint A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy
    Patricia L Judson
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis, MN 55455, USA
    Gynecol Oncol 95:226-30. 2004
  4. ncbi request reprint Trends in the incidence of invasive and in situ vulvar carcinoma
    Patricia L Judson
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Obstet Gynecol 107:1018-22. 2006
  5. doi request reprint A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer
    Melissa A Geller
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA
    Gynecol Oncol 121:112-7. 2011
  6. doi request reprint Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
    Melissa A Geller
    Department of Obstetrics, Gynecology and Women s Health, University of Minnesota, MMC 395 420 Delaware St SE, Minneapolis, MN, 55455, USA
    Cancer Immunol Immunother 59:1877-84. 2010
  7. doi request reprint Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: a pilot study
    Peter A Argenta
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA
    Gynecol Oncol 129:81-5. 2013
  8. doi request reprint Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial
    Levi S Downs
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN 55455, USA
    Gynecol Oncol 120:265-9. 2011
  9. doi request reprint A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer
    Peter A Argenta
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis MN 55455, USA
    Gynecol Oncol 113:205-9. 2009
  10. ncbi request reprint Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression
    Melissa A Geller
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA
    Gynecol Oncol 95:632-6. 2004

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer
    Patricia L Judson
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, 420 Delaware Street Southeast, MMC 395, Minneapolis, MN 55455, USA
    Gynecol Oncol 91:389-94. 2003
    ....
  2. ncbi request reprint A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer
    Patricia L Judson
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis, MN 55455, USA
    Gynecol Oncol 93:667-70. 2004
    ..To identify the nature and degree of toxicity of Temozolomide in this group of patients...
  3. ncbi request reprint A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy
    Patricia L Judson
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis, MN 55455, USA
    Gynecol Oncol 95:226-30. 2004
    ....
  4. ncbi request reprint Trends in the incidence of invasive and in situ vulvar carcinoma
    Patricia L Judson
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Obstet Gynecol 107:1018-22. 2006
    ..To characterize the incidence of vulvar carcinoma in situ and vulvar cancer over time...
  5. doi request reprint A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer
    Melissa A Geller
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA
    Gynecol Oncol 121:112-7. 2011
    ..To determine feasibility and efficacy of administering docetaxel and carboplatin chemotherapy followed by pelvic radiotherapy and then consolidation chemotherapy in patients with advanced or recurrent endometrial cancer...
  6. doi request reprint Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
    Melissa A Geller
    Department of Obstetrics, Gynecology and Women s Health, University of Minnesota, MMC 395 420 Delaware St SE, Minneapolis, MN, 55455, USA
    Cancer Immunol Immunother 59:1877-84. 2010
    ..Secondary objectives included assessment of safety and immune system activation...
  7. doi request reprint Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: a pilot study
    Peter A Argenta
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA
    Gynecol Oncol 129:81-5. 2013
    ..We aimed to evaluate the feasibility and tolerability of hyperthermic intraperitoneal carboplatin (HIPEC-carboplatin) following secondary cytoreduction for recurrent, platinum-sensitive ovarian cancer...
  8. doi request reprint Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial
    Levi S Downs
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN 55455, USA
    Gynecol Oncol 120:265-9. 2011
    ....
  9. doi request reprint A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer
    Peter A Argenta
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis MN 55455, USA
    Gynecol Oncol 113:205-9. 2009
    ..Grade 1 toxicity included headache (1 patient) and bromidrosis (2 patients). Conclusions. Fulvestrant is well-tolerated and efficacious. Objective response rates are low, but disease stabilization was common...
  10. ncbi request reprint Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression
    Melissa A Geller
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA
    Gynecol Oncol 95:632-6. 2004
    ..With the successful application of directed biological therapy in other sarcomas, a review of the behavior and biology of this disease is warranted...
  11. ncbi request reprint Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical cancer
    Peter A Argenta
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA
    Gynecol Oncol 97:659-61. 2005
    ..This option is particularly appealing for younger or nulliparous patients, in whom fertility may be highly desired...
  12. ncbi request reprint A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma
    Levi S Downs
    Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Cancer 112:331-9. 2008
    ..Thalidomide is an antiangiogenic agent with immune modulating potential. The objective of this study was to determine response rates among women who were treated for recurrent ovarian cancer using topotecan with or without thalidomide...
  13. ncbi request reprint Routine pelvic examination during front-line chemotherapy for ovarian cancer: should it play a role?
    Peter A Argenta
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis, USA
    J Reprod Med 53:3-7. 2008
    ..To determine if pelvic examination affected management in patients undergoing first-line chemotherapy for ovarian cancer and to determine a threshold of change in tumor size reliably detectable by pelvic examination...
  14. ncbi request reprint On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus
    Kathryn E Dusenbery
    Department of Therapeutic Radiology Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA
    Am J Clin Oncol 28:295-300. 2005
    ....
  15. pmc A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
    Melissa A Geller
    Obstetrics and Gynecology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA
    Cytotherapy 13:98-107. 2011
    ..We evaluated the tumor response and in vivo expansion of allogeneic NK cells in recurrent ovarian and breast cancer...
  16. doi request reprint Learning about ovarian cancer at the time of diagnosis: video versus usual care
    Melissa A Geller
    Obstetrics and Gynecology, University of Minnesota, Minneapolis, MN, USA
    Gynecol Oncol 119:370-5. 2010
    ..We evaluated the effects of an educational video on patients' distress, cancer knowledge, coping skills and attitudes regarding learning about cancer at the time of ovarian cancer diagnosis...
  17. doi request reprint Solitary fibrous tumors arising from the female pelvis
    Thanasak Sueblinvong
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology University of Minnesota, Minneapolis, Minnesota, USA
    Obstet Gynecol 118:470-4. 2011
    ..Solitary fibrous tumor arising from the female genital tract is extremely rare and the management of this condition is controversial...
  18. doi request reprint Feasibility and morbidity of using saline filled tissue expanders to reduce radiation-induced bowel injury in patients with gynecologic malignancies
    Melissa A Geller
    Division of Gynecologic Oncology, University of Minnesota, Department of Obstetrics, Gynecology and Women s Health, Minneapolis, MN 55455, USA
    Eur J Obstet Gynecol Reprod Biol 143:93-7. 2009
    ..To evaluate the feasibility and morbidity of using saline filled tissue expanders (TE) to displace the small bowel during radiation therapy in patients with gynecologic malignancies...
  19. ncbi request reprint Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer
    Justin C Chura
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN 55455, USA
    Gynecol Oncol 107:326-30. 2007
    ..To investigate the efficacy and safety of bevacizumab in heavily pretreated patients with recurrent ovarian cancer...
  20. ncbi request reprint Hysteroscopy and cytology in endometrial cancer
    William H Bradley
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecology Oncology, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Obstet Gynecol 104:1030-3. 2004
    ..To estimate the effect of preoperative diagnostic hysteroscopy on peritoneal cytology in patients with endometrial cancer...
  21. ncbi request reprint A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer
    Levi S Downs
    Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota Medical School, Minneapolis, MN 55455, USA
    Gynecol Oncol 95:347-51. 2004
    ..To determine toxicity and establish a maximum tolerated dose of outpatient therapy with ifosfamide, paclitaxel, and carboplatin in women with advanced and recurrent cervical cancer...
  22. ncbi request reprint Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review
    Justin C Chura
    University of Minnesota, Department of Obstetrics, Gynecology, and Women s Health, 420 Delaware Street SE MMC 395, Minneapolis, MN 55455, USA
    Gynecol Oncol 104:247-52. 2007
    ..Studies have suggested that PET scans can differentiate between leiomyomas and leiomyosarcomas. Our experience, however, shows that PET scan-positive smooth muscle tumors are not necessarily malignant...
  23. ncbi request reprint Stage II squamous cell carcinoma of the vagina in a patient with Bloom syndrome: a case report
    Christine S Goudge
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women s Health, University of Minnesota, 420 Delaware Street SE, MMC 395, Minneapolis, MN 55455, USA
    J Reprod Med 52:557-9. 2007
    ..Bloom syndrome (BS) is a rare autosomal recessive disorder characterized by dwarfism and a predisposition to cancer. Squamous cell vaginal cancer is also quite rare and has not before been reported in association with BS...
  24. ncbi request reprint CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer
    Zhengyan Zhang
    Department of Obstetrics and Gynecology, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8064, St Louis, MO 63110, USA
    Cancer Res 67:11202-8. 2007
    ..None of seven nearby genes was differentially expressed in cervical cancer. The importance of CD83 in epithelial versus dendritic cells needs to be determined, as does its role in promoting cervical cancer...